Status:
RECRUITING
Liver Cancer Registry Platform
Lead Sponsor:
iOMEDICO AG
Conditions:
Hepatocellular Carcinoma (HCC)
Cholangiocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristi...
Detailed Description
JADE is a national, observational, prospective, longitudinal, multicenter cohort study (tumor registry platform) with the purpose to record information on the antineoplastic treatment of HCC or CCC in...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Confirmed hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCC) als early, intermediate or advanced/metastatic stage
- Age ≥ 18 years
- Signed and dated informed consent (IC):
- For participation in the PRO module: Before primary locoregional therapy or start of first systemic treatment
- For no participation in the PRO module: No later than 8 weeks after primary locoregional therapy or start of first systemic treatment
- Exclusion criteria:
- Patients treated with best supportive care (BSC) only (i.e. no surgery, no radiotherapy, no ablative procedures, no systemic anti-tumoral therapies)
Exclusion
Key Trial Info
Start Date :
August 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04510740
Start Date
August 9 2020
End Date
December 1 2027
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple sites all over germany
Multiple Locations, Germany